Clinical Trial Detail

NCT ID NCT02764541
Title Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Dana-Farber Cancer Institute
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Letrozole

Tamoxifen

Age Groups: adult

Additional content available in CKB BOOST